Patents/Assignees

Celgene Corporation

68 patents in portfolio

US11629335utility2023
Methods of Improving Vector Transduction Efficiency Into T Lymphocytes
0 cites
US11626210utility2023
Digital Health Prognostic Analyzer for Multiple Myeloma Mortality Predictions
0 cites
US11590117utility2023
Treatment of a Hematologic Malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0 cites
US11591390utility2023
Sirp-α Binding Proteins and Methods of Use Thereof
0 cites
US11583536utility2023
Substituted 4-aminoisoindoline-1,3-dione Compounds and Second Active Agents for Combined Use
0 cites
US11578056utility2023
Solid Forms Comprising (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and Salts Thereof, and Compositions Comprising and Methods of Using the Same
0 cites
US11571436utility2023
Oral Formulations of Cytidine Analogs and Methods of Use Thereof
0 cites
US11560371utility2023
Cereblon Binding Compounds, Compositions Thereof, and Methods of Treatment Therewith
0 cites

← PreviousPage 4 of 4